Using MRI to Improve Treatment for Sigmoid Colon Cancer
Official title: Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers
Run by Imperial College London · NCT02222844 · Data updated 2026-11-12
This study is testing if using MRI scans can help doctors plan better treatments for patients with sigmoid colon cancer compared to regular CT scans.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 244 (estimated) |
| Sponsor | Imperial College London Academic / other |
| Locations | 16 sites (Huntingdon, Cambridgeshire and 15 other locations) |
| Status | Recruiting |
| Started | August 2014 |
| Main results expected | December 2026 |
| Study ends | December 2031 |
| Registry record updated | October 17, 2024 |
| Trial ID | NCT02222844 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 16 and over with suspected or proven sigmoid colon adenocarcinoma who are eligible for curative treatment.
✕Probably not a fit
Patients with metastatic disease, contraindications for MRI, or severe co-morbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates whether MRI imaging can enhance the treatment planning for patients with suspected or confirmed sigmoid colon adenocarcinoma who are eligible for curative treatment. Participants are randomly assigned to either a control group receiving standard preoperative CT imaging or an intervention group that includes MRI imaging. The study aims to determine if MRI can identify high-risk tumors more effectively than CT, potentially altering treatment plans based on additional diagnostic information. Patients will be followed up at 1 and 3 years to assess outcomes and quality of life.
Why it matters
Potential benefit: If successful, this approach could lead to more personalized and effective treatment plans for patients with sigmoid colon cancer.
How similar studies have gone: Other studies have shown that advanced imaging techniques like MRI can improve treatment outcomes in various cancers, suggesting a promising avenue for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Have a suspected or proven sigmoid colon adenocarcinoma 2. Is eligible for curative treatment 3. Has no irresectable metastatic disease 4. MRI can be reviewed by an MDT prior to surgery 5. Has no decision regarding radical treatment 6. Have provided written informed consent to participate in the study 7. Be aged 16 years or over Exclusion Criteria: 1. Have metastatic disease (including resectable liver metastases) 2. Have a synchronous second malignancy 3. Are contraindicated for MRI 4. Are contraindicated for or have allergy to Buscopan (e.g. glaucoma, small or large bowel obstruction, GFR\<30) 5. Have severe co-morbidities or previous medical history that prevent the application of eventual chemo/radiotherapy
Where it's running
-
Hinchingbrooke Hospital
Huntingdon, Cambridgeshire, United Kingdom Recruiting -
Leighton Hospital
Crewe, Cheshire, United Kingdom Recruiting -
University Hospital of North Tees
Stockton-on-Tees, County Durham, United Kingdom Recruiting -
Croydon University Hospital
Thornton Heath, Croydon, United Kingdom Recruiting -
Chesterfield Royal
Chesterfield, Derbyshire, United Kingdom Recruiting -
Queen Alexandra Hospital
Portsmouth, Hampshire, United Kingdom Recruiting
Show 10 more locations
-
St Mark's Hospital
Middlesex, Harrow, United Kingdom Recruiting -
Maidstone Hospital
Maidstone, Kent, United Kingdom Recruiting -
Queen Elizabeth the Queen Mother Hospital
Margate, Kent, United Kingdom Recruiting -
North Manchester General Hospital
Crumpsall, Manchester, United Kingdom Recruiting -
University Hospital of South Manchester & Manchester Royal Infirmary
Wythenshawe, Manchester, United Kingdom Recruiting -
Harrogate District Hospital
Harrogate, North Yorkshire, United Kingdom Recruiting -
Musgrove Park Hospital
Taunton, Somerset, United Kingdom Recruiting -
Royal Marsden Hospital
Sutton, Surrey, United Kingdom Recruiting -
Salisbury District Hospital
Salisbury, Whiltshire, United Kingdom Recruiting -
Yeovil District Hospital
Yeovil, Somerset, United Kingdom Active not recruiting
Study contacts
- Principal investigator: Gina Brown — Imperial College London
- Study coordinator: Caroline Martin
- Email: c.martin1@imperial.ac.uk
- Phone: +44 (0) 7749 655 817
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biomarkers in Colorectal Cancer: A Longitudinal Study Using Biobanks and Blood Samples
This study tests whether clinical and molecular biomarkers from tumor tissue and blood can predict treatment response, recurrence, and survival in adults with colorectal cancer undergoing surgery.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
ctDNA blood test to spot buried cancer after surgery or treatment in colorectal cancer
A blood test that looks for specific KRAS mutations in circulating tumor DNA to see if colorectal cancer has left residual disease or is likely to relapse.
-
Multimodal Survival Predictor for Colorectal Liver Metastases After Surgery
Researchers are testing a tool that combines MRI-derived tumor features with clinical data to predict survival after surgery for colorectal liver metastases.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
AI-powered stool image analysis to see if it matches FIT results in colorectal cancer screening
We’re testing whether AI-derived features from stool images can align with FIT results in adults being screened or evaluated for colorectal neoplasia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.